Terug
Dagbereik
€ 109,97
€ 118,88
52-Weeksbereik
€ 18,23
€ 151,18
Volume
246.172
50D / 200D Gem.
€ 103,28
/
€ 71,39
Vorige Slotkoers
€ 112,50
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -79,5 | 0,4 |
| P/B | 22,1 | 2,9 |
| ROE % | -59,4 | 3,8 |
| Net Margin % | — | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 203,92
+74.2%
Low: € 143,00
High: € 255,00
Forward WPA
-€ 3,88
Omzet Sch.
27000
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2029 |
€ 7,28
€ 7,28 – € 7,28
|
310 M | 4 |
| FY2028 |
-€ 0,74
-€ 7,04 – € 11,06
|
130 M | 10 |
| FY2027 |
-€ 4,99
-€ 9,33 – -€ 2,66
|
25 M | 11 |
Belangrijkste Punten
Earnings declined -193,27% over the past year
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -10,84M
PEG of 0,01 suggests growth is underpriced
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)-193,27%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-59,37%
ROIC-16,89%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,00
Current Ratio7,33
Interest Coverage-3,27
Waardering
P/E Ratio
-79,47
P/B Ratio22,13
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | -193,27% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -17,43M |
| ROE | -59,37% | ROA | -19,76% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -10,84M |
| ROIC | -16,89% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 7,33 |
| Interest Coverage | -3,27 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -79,47 | P/B Ratio | 22,13 |
| P/S Ratio | N/A | PEG Ratio | 0,01 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,39B | Enterprise Value | 1,30B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 25,90M | 31,42M |
| Net Income | -17,43M | 18,69M | -33,28M | -45,74M |
| EPS (Diluted) | -7,83 | 14,74 | -29,61 | -56,69 |
| Gross Profit | 0,0 | 0,0 | 23,12M | 29,05M |
| Operating Income | -14,10M | -11,87M | -43,47M | -51,83M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 88,23M | 7,55M | 16,52M | 153,56M | 105,01M |
| Total Liabilities | 25,63M | 11,43M | 39,70M | 102,81M | 73,98M |
| Shareholders' Equity | 62,61M | -3,88M | -23,17M | 50,76M | 31,03M |
| Total Debt | 0,0 | 0,0 | 0,0 | 14,89M | 16,96M |
| Cash & Equivalents | 83,60M | 7,35M | 16,05M | 117,76M | 70,44M |
| Current Assets | 88,23M | 7,55M | 16,52M | 127,63M | 75,72M |
| Current Liabilities | 12,04M | 2,36M | 5,78M | 50,56M | 22,15M |